CNTB — Connect Biopharma Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Connect Biopharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	20-F	20-F	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	fx Final	Final	Final	Final	Final
Net Income/Starting Line	-113	-202	-118	-62.1	-15.6
Depreciation
Amortisation
Non-Cash Items	88.9	113	8.78	3.79	6.85
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-0.413	3.58	6.46	9.85	-15.5
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	-24.2	-84.3	-102	-47.7	-23.6
Capital Expenditures	-2.22	-3.88	-4.41	-0.081	-0.75
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2.64	-1.32	-81.8	75.1	-2.7
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.425	-5.21	-86.2	75	-3.45
Financing Cash Flow Items	-0.572	-17.1	0	0.044	0.033
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	133	202	-0.085	0.045	0.227
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	102	113	-189	26.7	-27.4